ADVANCED MIC.DEV. DL-,01/ US0079031078 /
2024-03-28 7:11:46 PM | Chg. +2.740 | Volume | Bid10:00:01 PM | Ask10:00:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
167.280EUR | +1.67% | 701 Turnover: 117,409.200 |
-Bid Size: - | -Ask Size: - | 270.31 bill.EUR | - | - |
GlobeNewswire
03-27
Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market G...
GlobeNewswire
03-26
Ocular Therapeutix™ To Present Data at the 2024 ASCRS Annual Meeting (American Society of Cataract a...
GlobeNewswire
03-26
Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
GlobeNewswire
03-22
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
GlobeNewswire
03-22
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
GlobeNewswire
03-22
Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for ...
GlobeNewswire
03-19
AMD Adaptive Computing Technology Powers Sony Semiconductor Solutions LiDAR Automotive Reference Des...
GlobeNewswire
03-19
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degene...
GlobeNewswire
03-18
Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million
GlobeNewswire
03-18
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pip...
GlobeNewswire
03-18
GraniteShares adds Amazon, AMD, and Microsoft to its 2X leveraged Single-Stock ETFs Lineup
GlobeNewswire
03-18
Mercury Announces Early Access Program for New Direct RF Multi-Chip Module Powered by AMD Versal Ada...
GlobeNewswire
03-12
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corp...
GlobeNewswire
03-12
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
GlobeNewswire
03-12
Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire
03-11
Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor